Article
The immunomodulatory properties of the HDAC6 inhibitor ACY241 supports robust anti-tumor…
medRxiv · 2021 · Arup Bag
Key facts
| Title | The immunomodulatory properties of the HDAC6 inhibitor ACY241 supports robust anti-tumor response in NSCLC when coupled with the chemotherapy drug Oxaliplatin |
|---|---|
| First author | Arup Bag |
| Journal | medRxiv |
| Published | Oct 2, 2021 |
| DOI | 10.1101/2021.10.01.462824 |
| Devices mentioned | BK110039, K010696, K103302 |
| Product codes mentioned | JIS, NDS, PCA, KIT, MVU, NJT, OOI, PFF, PFT |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1